CYP2B6 c.511T>C ;(p.F171L)

Variant ID: 19-41512836-T-C

NM_000767.4(CYP2B6):c.511T>C;(p.F171L)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.

Nature Communications
Wagner, Alex H AH; Devarakonda, Siddhartha S; Skidmore, Zachary L ZL; Krysiak, Kilannin K; Ramu, Avinash A; Trani, Lee L; Kunisaki, Jason J; Masood, Ashiq A; Waqar, Saiama N SN; Spies, Nicholas C NC; Morgensztern, Daniel D; Waligorski, Jason J; Ponce, Jennifer J; Fulton, Robert S RS; Maggi, Leonard B LB; Weber, Jason D JD; Watson, Mark A MA; O'Conor, Christopher J CJ; Ritter, Jon H JH; Olsen, Rachelle R RR; Cheng, Haixia H; Mukhopadhyay, Anandaroop A; Can, Ismail I; Cessna, Melissa H MH; Oliver, Trudy G TG; Mardis, Elaine R ER; Wilson, Richard K RK; Griffith, Malachi M; Griffith, Obi L OL; Govindan, Ramaswamy R
Publication Date: 2018-09-17

Variant appearance in text: CYP2B6: F171L
PubMed Link: 30224629
Variant Present in the following documents:
  • 41467_2018_6162_MOESM13_ESM.xlsx, sheet 1
View BVdb publication page



Complex effects of rexinoids on ligand dependent activation or inhibition of the xenobiotic receptor, CAR.

Nuclear Receptor
Tzameli, Iphigenia I; Chua, Steven S SS; Cheskis, Boris B; Moore, David D DD
Publication Date: 2003-06-06

Variant appearance in text: CYP2B6: F171L
PubMed Link: 12904257
Variant Present in the following documents:
  • Main text
  • 1478-1336-1-2.pdf
View BVdb publication page



The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR.

Molecular And Cellular Biology
Tzameli, I I; Pissios, P P; Schuetz, E G EG; Moore, D D DD
Publication Date: 2000-05

Variant appearance in text: CYP2B6: F171L
PubMed Link: 10757780
Variant Present in the following documents:
  • Main text
View BVdb publication page